Calendar

Week of Sep 29, 2025

Sep 29, 2025grant324d agoDIGITAL INFUZION, INC. — THE SCOPE OF THIS PROCUREMENT IS TO DEVELOP, REFINE, DEPLOY, VALIDATE, MAINTA...

OD grant. $3,804,755. PI: KAREN A. STARK

full page →nih reporter ↗

Sep 29, 2025grant324d agoMEDICAL UNIVERSITY OF SOUTH CAROLINA — Exploring a role for mPFC CRF circuitry in promoting stress-enhanced alcohol ...

AA grant. $49,538. PI: Kathryn Anne Carter

full page →nih reporter ↗

Sep 29, 2025grant324d agoBOSTON CHILDREN'S HOSPITAL — Metagenomic Profiling of Dust Samples for School-based Viral SurveillanceBoston Children's Hospital

AI grant. $90,946. PI: Ye Sun

full page →nih reporter ↗

Sep 30, 2025approval323d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

Sponsor: AMNEAL. Form: TABLET. Route: ORAL

full page →DOXYCYCLINE HYCLATE →fda approvals ↗

Sep 30, 2025approval323d agoTRAMADOL HYDROCHLORIDE — FDA approvaltramadol hydrochloride ER

Sponsor: MYLAN. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →tramadol hydrochloride ER →fda approvals ↗

Sep 30, 2025approval323d agoMIFEPREX (MIFEPRISTONE) — FDA approvalCORCEPT THERAPEUTICS INC

Sponsor: DANCO LABS LLC. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Sep 30, 2025approval323d agoQULIPTA (ATOGEPANT) — FDA approvalatogepant

Sponsor: ABBVIE. Form: TABLET. Route: ORAL

full page →atogepant →fda approvals ↗

Sep 30, 2025approval323d agoMIFEPRISTONE — FDA approvalMIFEPRISTONE

Sponsor: GENBIOPRO. Form: TABLET. Route: ORAL

full page →MIFEPRISTONE →fda approvals ↗

Sep 30, 2025approval323d agoOLANZAPINE — FDA approvalZydus Therapeutics Inc

Sponsor: ZYDUS PHARMS. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

full page →fda approvals ↗

Sep 30, 2025approval323d agoLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalMacleods Pharmaceuticals Ltd

Sponsor: IPCA LABS LTD. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Sep 30, 2025approval323d agoIRBESARTAN — FDA approvalIRBESARTAN

Sponsor: HETERO LABS LTD V. Form: TABLET. Route: ORAL

full page →IRBESARTAN →fda approvals ↗

Sep 30, 2025approval323d agoVORICONAZOLE — FDA approvalGreenstone LLC

Sponsor: NOVEL LABS INC. Form: FOR SUSPENSION. Route: ORAL

full page →fda approvals ↗

Sep 30, 2025approval323d agoOLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

full page →ALDACTAZIDE →fda approvals ↗

Sep 30, 2025approval323d agoTEGRETOL-XR (CARBAMAZEPINE) — FDA approvalcarbamazepine ER

Sponsor: NOVARTIS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →carbamazepine ER →fda approvals ↗

Sep 30, 2025approval323d agoFENOFIBRIC ACID (CHOLINE FENOFIBRATE) — FDA approvalcholine fenofibrate

Sponsor: ACTAVIS ELIZABETH. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

full page →choline fenofibrate →fda approvals ↗

Sep 30, 2025approval323d agoPREGABALIN — FDA approvalPREGABALIN

Sponsor: STRIDES PHARMA. Form: CAPSULE. Route: ORAL

full page →PREGABALIN →fda approvals ↗

Sep 30, 2025approval323d agoTEGRETOL (CARBAMAZEPINE) — FDA approvalcarbamazepine ER

Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

full page →carbamazepine ER →fda approvals ↗

Sep 30, 2025approval323d agoRHAPSIDO (REMIBRUTINIB) — FDA approvalremibrutinib

Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

full page →remibrutinib →fda approvals ↗

Sep 30, 2025approval323d agoMIFEPRISTONE — FDA approvalMIFEPRISTONE

Sponsor: EVITA SOLUTIONS. Form: TABLET. Route: ORAL

full page →MIFEPRISTONE →fda approvals ↗

Sep 30, 2025approval323d agoTIZANIDINE HYDROCHLORIDE — FDA approvalRiconpharma LLC

Sponsor: ALKEM LABS LTD. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Sep 30, 2025approval323d agoVORICONAZOLE — FDA approvalVORICONAZOLE

Sponsor: MEITHEAL. Form: POWDER. Route: INTRAVENOUS

full page →VORICONAZOLE →fda approvals ↗